萬辰生物(300972.SZ):擬推1209.5萬股的2023年限制性股票激勵計劃
格隆匯3月7日丨萬辰生物(300972.SZ)公佈2023年限制性股票激勵計劃(草案),該激勵計劃擬授予激勵對象的限制性股票數量為1209.50萬股,約佔該激勵計劃草案公佈日公司股本總額15,350.00萬股的7.88%。此次授予為一次性授予,無預留權益。
該激勵計劃授予限制性股票的授予價格為12.07元/股。
該激勵計劃授予的激勵對象共計42人,包括公司公吿該激勵計劃時在公司(含子公司,下同)任職的核心業務人員和骨幹員工,不含萬辰生物董事、高級管理人員、獨立董事、監事、單獨或合計持有公司5%以上股份的股東或實際控制人及其配偶、父母、子女以及外籍員工。
該激勵計劃的有效期為自限制性股票授予之日起至激勵對象獲授的限制性股票全部歸屬或作廢失效之日止,最長不超過48個月。該激勵計劃授予的限制性股票在授予日起滿12個月後分三期歸屬,歸屬的比例分別為40%、40%、20%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.